Search

In Stock

Buy Symkevi (tezacaftor/ivacaftor) Online

DISEASE INDICATIONS: Cystic Fibrosis

MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Symkevi is specifically designed to address the underlying genetic defect in individuals with CF who have specific responsive mutations.

$5,729.85

Clear
Compare

Symkevi is a pharmaceutical medication that combines two active ingredients, tezacaftor and ivacaftor, to treat cystic fibrosis (CF), a genetic disorder that primarily affects the respiratory and digestive systems. Symkevi is specifically designed to address the underlying genetic defect in individuals with CF who have specific responsive mutations.

Here is a detailed description of Symkevi, which is essentially a combination of tezacaftor and ivacaftor:

Name: Symkevi (Combination of Tezacaftor and Ivacaftor)

Active Ingredients:

  1. Tezacaftor: Tezacaftor is a CFTR corrector medication. It assists the defective CFTR protein in the cells of the respiratory system to fold properly and move to the cell surface. This helps the CFTR protein function more effectively in regulating the flow of salt and fluids in and out of the cells, leading to improved mucus clearance and reduced mucus thickness in the airways.
  2. Ivacaftor: Ivacaftor is a CFTR potentiator medication. It enhances the function of the CFTR protein that has reached the cell surface, increasing chloride ion transport. This further improves airway surface hydration and reduces the thickness of mucus, making it easier to clear.

Indications: Symkevi is indicated for the treatment of cystic fibrosis in patients who have specific genetic mutations that are responsive to this combination therapy. These mutations must be identified through genetic testing to determine if the patient is eligible for treatment with Symkevi.

Dosage Forms: Symkevi is available in the form of oral tablets, which are taken by mouth.

Usage: The dosing and administration of Symkevi are determined by a healthcare provider and are based on the patient’s age, weight, and specific genetic mutations. It is generally taken as prescribed, usually once or twice daily with fat-containing food to optimize absorption.

Benefits: Symkevi offers the potential to improve lung function, reduce respiratory symptoms, and enhance the overall quality of life for individuals with cystic fibrosis who have specific responsive mutations. While it is not a cure for CF, it can help manage the underlying genetic defect and improve the patient’s health and well-being.

Precautions: Patients must undergo genetic testing to identify the specific mutations that make them eligible for Symkevi treatment. It is crucial to use Symkevi as directed by a healthcare provider and to be aware of potential side effects and drug interactions.

Side Effects: Common side effects of Symkevi may include respiratory symptoms such as shortness of breath, cough, and chest tightness. Other possible side effects can include headache, nausea, and elevated liver enzymes. Patients should discuss any side effects or concerns with their healthcare provider.

In conclusion, Symkevi (tezacaftor/ivacaftor) is a combination medication used to treat cystic fibrosis in individuals with specific responsive mutations. It addresses the underlying genetic defect to improve lung function and reduce respiratory symptoms associated with CF. Patients should use it as directed by their healthcare provider and be aware of potential side effects and precautions associated with its use. Symkevi is a valuable addition to the treatment options available to individuals with cystic fibrosis, helping to improve their quality of life.

Package

28 tablets of 100 mg/150 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Symkevi (tezacaftor/ivacaftor) Online

$5,729.85
(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Symkevi is specifically designed to address the underlying genetic defect in individuals with CF who have specific responsive mutations.

Buy Yupelri (revefenacin) Online

(0 Reviews)
DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease MANUFACTURER: Theravance Biopharma USAGE: Oral MEDICINE APPROVED BY: Food and Drug Administration (FDA) Yupelri is a pharmaceutical medication used to treat chronic obstructive pulmonary disease (COPD), a chronic respiratory condition characterized by difficulty breathing, coughing, and wheezing.

Buy Tezspire (tezepelumab-ekko) Online

$6,696.25
(0 Reviews)
DISEASE INDICATIONS: Asthma MANUFACTURER: Amgen / AstraZeneca AB USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA)   Tezspire (tezepelumab-ekko) is a prescription medication that belongs to the drug class of monoclonal antibodies. It is used to treat severe asthma in adults and children 12 years of age and older whose condition cannot be managed by their existing asthma medication. Tezspire is the first and only biologic approved for severe asthma without phenotypic or biomarker limitations.

Buy Trikafta (elexacaftor/tezacaftor/ivacaftor; ivacaftor) Online

From $39,106.10
(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals Incorporated USAGE: Oral MEDICINE APPROVED BY: Food and Drug Administration (FDA)   Trikafta is designed to address the underlying genetic mutations in individuals with CF and has been shown to significantly improve lung function and overall health in many patients.

Buy Orkambi (lumacaftor/ivacaftor) Online

From $10,806.14
(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Therapeutic Goods Administration (TGA) This medication is designed to address the underlying cause of CF in individuals who have two copies of the F508del mutation in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene, which is a common genetic mutation associated with CF.

Buy Symdeko (tezacaftor / ivacaftor) Online

$39,418.95
(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) , Symdeko is indicated for the treatment of patients with CF who have specific genetic mutations that are responsive to these medications. This combination therapy addresses the underlying cause of CF by improving the function of the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) protein, which is often dysfunctional in CF patients.

Buy Kalydeco (ivacaftor) Online

From $7,241.59
(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Kalydeco (ivacaftor) is a medication prescribed for individuals with cystic fibrosis (CF) who are 4 months of age and older and possess at least one CF gene mutation that responds to Kalydeco treatment.

Back to Top
Product has been added to your cart